Table of contents
2024 - Volume 11 - Suppl 1
Abstracts of the International Conference of Porphyrins and Porphyrias, Pamplona, Spain, 21–25 September 2024
Session 1 – Guidelines for treatment and follow-up (September 22nd, 2024)
Thematic area: diagnosis and care in porphyrias
Session 2 – Genetic and molecular mechanisms of heme synthesis and regulation (September 23rd, 2024)
- 04124 Shapes and patterns of heme-binding motifs in mammalian heme-binding proteins (20 September, 2024)
Thematic area: recent advances in the pathophysiology of porphyrias
Thematic area: heme synthesis and regulation
Session 4 – Heme in pathophysiology (September 23rd, 2024)
- 04108 Characterization of heme-induced toxicity and ferroptosis in placental cells (20 September, 2024)
- 04162 Role of heme as a modulator of blood coagulation proteins (20 September, 2024)
Thematic area: heme synthesis and regulation
Session 6 – Current therapies for acute hepatic porphyrias (AHP) (September 24th, 2024)
Thematic area: current and emerging therapies for porphyrias
Session 7 – New insights and potential treatment approaches in erythropoietic porphyrias (September 24th, 2024)
Thematic area: current and emerging therapies for porphyrias
Session 9 – Rational approach(es) to diagnosis and care in AHPS (September 25th, 2024)
Thematic area: current and emerging therapies for porphyrias
Thematic area: diagnosis and care in porphyrias
Thematic area: current and emerging therapies for porphyrias
Thematic area: recent advances in the pathophysiology of porphyrias
Thematic area: current and emerging therapies for porphyrias
Thematic area: diagnosis and care in porphyrias
Session 10 – Rational approach(es) to diagnosis and care in cutaneous porphyrias (September 25th, 2024)
Thematic area: diagnosis and care in porphyrias
Thematic area: recent advances in the pathophysiology of porphyrias
Session 10 – Expert panel: diagnostic and clinical conundrums. critical issues to resolve and future directions (September 25th, 2024)
- 04147 C-type lectin 10A as a potential biomarker in acute intermittent porphyria (20 September, 2024)
- 04186 51-year-follow-up of a patient with Doss-Porphyria in times of givosiran (20 September, 2024)
- 04244 Mental health in the porphyrias (20 September, 2024)
Thematic area: diagnosis and care in porphyrias
Posters
- 04167 Hemin treatment during attacks in argentinean patients with acute porphyrias (20 September, 2024)
- 04103 Effect of Givosiran for hereditary coproporphyria: 2 cases report (20 September, 2024)
- 04110 Porphyria registry padova – start up (20 September, 2024)
- 04095 Hormonal treatments in acute hepatic porphyria (20 September, 2024)
- 04088 Variegate porphyria cases with faecal isocoproporphyrin – not dual porphyria (20 September, 2024)
- 04166 Understanding variegate porphyria in an hiv patient: a detailed case study (20 September, 2024)
- 04187 The genetic landscape of porphyria in Ireland (20 September, 2024)
- 04193 The incidance of types of porphyria and their symptoms in Turkey (20 September, 2024)
- 04151 Erythropoietic protoporphyria: explaining the North-South gap (20 September, 2024)
- 04141 Investigation for porphyria in Denmark (20 September, 2024)
- 04143 A real-life overview of diet patterns and acute hepatic porphyria (20 September, 2024)
- 04142 Sleep and stress in patients with acute intermittent porphyria (20 September, 2024)
- 04131 Increased pancreatic enzymes in a patient with acute intermittent porphyria (20 September, 2024)
- 04087 Acquired erythropoietic protoporphyria due to myelodysplastic syndrome (20 September, 2024)
- 04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report (20 September, 2024)
- 04109 The impact of erythropoietic protoporphyria (EPP) on family quality of life (20 September, 2024)
- 04164 Hepatic porphyrias onset. The role of NR1/2 gene variants (20 September, 2024)
- 04174 A congenital erythropoietic porphyria case of unknown genetic mutation (20 September, 2024)